1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
MC Endeavors, Inc.

MC Endeavors, Inc.

MSMY
MC Endeavors, Inc.US flagOther OTC
0.00
USD
- -
- -
546,113.00Market Cap
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
- -
Basic EPS, GAAP
-0.03
-0.1
-0.04
-0.08
-0.06
-0.02
-0.02
-0.01
-0.05
-0.02
-0.02
Free Cash Flow per Basic Share
-0.03
-0.07
-0.02
-0.05
-0.04
-0.01
-0.01
-0.01
-0.03
-0.02
-0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
-0.01
- -
-0.01
-0.01
-0.24
-0.21
-0.22
-0.18
-0.17
Tangible Book Value per Share
- -
- -
-0.01
- -
-0.01
-0.01
-0.01
-0.01
-0.01
- -
- -
Basic Weighted Avg Shares
7
8
9
11
12
13
15
19
23
30
35
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
-64,775.26
-2,898,304.55
-416,816.12
- -
- -
- -
-779.09
-4,347.2
-400.8
-379.75
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
- -
-1
-1
- -
- -
- -
-1
-1
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
-64,775.26
-1,456,877.27
-208,771.96
- -
- -
- -
-845.48
-4,379.18
-405.76
-381.46
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-2,877.7
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Apr'10
Jul'11
Oct'11
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
10
Market Capitalization
1
1
4

Working Capital

FRC

•

in mil. unless spec.
Apr'10
Jul'11
Oct'11
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-38.12%
-203.89%
Free Cash Flow
- -
50.59%
-13.86%
Net Income, GAAP
- -
50.5%
-40.49%
Sales/Revenue/Turnover
- -
- -
542.25%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
-0.01
- -
-0.01
- -
-0.05
2010
- -
-0.01
- -
- -
-0.02
2011
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2009
- -
- -
- -
- -
- -
2010
- -
- -
- -
- -
- -
2011
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Steven Mazurek
Full Time Employees
3
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
3865 Mariana Unit C Dana Point CA United States of America 92629
IPO Date
Aug 2, 2010
CIK
0001157509
Website
mcendeavors.com
Similar Companies
Vifor Pharma AG (VIFN.SW)
Endo International plc (ENDP)
Intra-Cellular Therapies, Inc. (ITCI)
Bio Essence Corporation (BIOE)
Beijing Science Sun Pharmaceutical Co., Ltd. (300485.SZ)
Torii Pharmaceutical Co., Ltd. (TRXPF)
Business
MC Endeavors, Inc. (MSMY) operates an unincorporated trucking business providing surface transportation, delivery, and logistic services in North America. The company offers trucking services as its principal product, encompassing freight and logistics operations; it previously provided turnkey CBD product production services through its former subsidiary Eclipse Liquids LLC and division CBD Liquid Labs, including research and development, component sourcing, custom formulation, brand and label design, label printing, contract and wholesale manufacturing, custom private label production, and lab-certified third-party testing, but spun off this unit in 2022. Incorporated in Nevada in 2001 as Mees Masonry Corporation and renamed MC Endeavors, Inc. in 2010, the company is headquartered in Torrance, California, with administrative offices in Gardena, California. In recent developments, MC Endeavors sold the company entity to YG Yoyo, LLC on March 8, 2022, without its subsidiaries or assets, leading to the divestiture of Eclipse Liquids and CBD Liquid Labs; the firm maintains outstanding convertible notes payable totaling approximately $205,070 as of September 30, 2025, and reports minimal assets of $496 in cash with ongoing net operating losses, including $16,853 for the nine months ended September 30, 2025. No recent partnerships, funding rounds, acquisitions, new product launches, or major expansions are reported within the last 1-2 years; the company focuses on basic operational sustainability amid financial challenges. Wilson Ndubueze Anaekwe serves as president, CEO, and director, controlling 100% of Series A Convertible Super Preferred Stock with super voting rights.

Company News

APIChat

  • defenseworld.net

    MC Endeavors Inc. (OTCMKTS:MSMY) Sees Significant Increase in Short Interest

  • defenseworld.net

    Analyzing MasTec (NYSE:MTZ) and MC Endeavors (OTCMKTS:MSMY)

  • defenseworld.net

    Granite Construction (NYSE:GVA) vs. MC Endeavors (OTCMKTS:MSMY) Head-To-Head Comparison